questionText: To ask the Secretary of State for Health and Social Care, what recent discussions she has had with (a) NICE and (b) pharmaceutical companies on the affordability of Kaftrio.
answerText: Departmental officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE), including in relation to the development of guidance on individual products. The Department has had no recent discu...
heading: Ivacaftor/tezacaftor/elexacaftor